Search Results - "Georgianos, Panagiotis"

Hypertension in chronic kidney disease—treatment standard 2023 by Georgianos, Panagiotis I, Agarwal, Rajiv

“…ABSTRACT Hypertension is very common and remains often poorly controlled in patients with chronic kidney disease (CKD). Accurate blood pressure (BP)…”
Get full text

Ambulatory Blood Pressure Reduction With SGLT-2 Inhibitors: Dose-Response Meta-analysis and Comparative Evaluation With Low-Dose Hydrochlorothiazide by Georgianos, Panagiotis I, Agarwal, Rajiv

“…Sodium-glucose cotransporter (SGLT)-2 inhibitors lower clinic and ambulatory blood pressure (BP), possibly through their natriuretic action. However, it…”
Get full text

Hypertension in Chronic Kidney Disease (CKD): Diagnosis, Classification, and Therapeutic Targets by Georgianos, Panagiotis I, Agarwal, Rajiv

“…Abstract Blood pressure (BP) in the office is often recorded without standardization of the technique of measurement. When office BP measurement is performed…”
Get full text

Advances in the area of cardiorenal medicine: clinical research highlights from selected papers published in NDT by Georgianos, Panagiotis I, Agarwal, Rajiv

Get full text

Revisiting RAAS blockade in CKD with newer potassium-binding drugs by Georgianos, Panagiotis I, Agarwal, Rajiv

“…Among patients with proteinuric chronic kidney disease (CKD), current guideline recommendations mandate the use of agents blocking the renin angiotensin…”
Get more information

Resistant Hypertension in Dialysis: Epidemiology, Diagnosis, and Management by Georgianos, Panagiotis I, Agarwal, Rajiv

“…Apparent treatment-resistant hypertension is defined as an elevated BP despite the use of ≥3 antihypertensive medications from different classes or the use of…”
Get more information

The Nonsteroidal Mineralocorticoid-Receptor-Antagonist Finerenone in Cardiorenal Medicine: A State-of-the-Art Review of the Literature by Georgianos, Panagiotis I, Agarwal, Rajiv

“…Abstract Steroidal mineralocorticoid-receptor-antagonists (MRAs), such as spironolactone and eplerenone, are guideline-directed therapies in patients with…”
Get full text

The glucagon-like peptide-1 receptor agonist semaglutide in diabetic kidney disease: A new kid on the block to afford maximal kidney protection by Georgianos, Panagiotis I, Leivaditis, Konstantinos, Liakopoulos, Vassilios

Get full text

Combination therapy with an SGLT‐2 inhibitor and finerenone in DKD: Are we there yet? by Georgianos, Panagiotis I., Eleftheriadis, Theodoros, Liakopoulos, Vassilios

Get full text

Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease by Agarwal, Rajiv, Georgianos, Panagiotis I

“…Insufficiency of 25-hydroxyvitamin D [25(OH)D] is highly prevalent among patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD) and is a…”
Get full text

How to deal with a hypertensive patient who has documented non-adherence to the prescribed antihypertensive therapy? by Georgianos, Panagiotis I., Divani, Maria, Liakopoulos, Vassilios

Get full text

Cooler dialysate temperature for the prevention of intradialytic hypotension: Is it time for a shift in our practice? by Georgianos, Panagiotis I., Vaios, Vasilis, Liakopoulos, Vassilios

Get full text

Blood Pressure and Mortality in Long-Term Hemodialysis-Time to Move Forward by Georgianos, Panagiotis I, Agarwal, Rajiv

“…Contrary to the direct, graded, and causal relationship of hypertension with cardiovascular outcomes in the general population, among dialysis patients, blood…”
Get full text

Resistant Hypertension in Chronic Kidney Disease (CKD): Prevalence, Treatment Particularities, and Research Agenda by Georgianos, Panagiotis I., Agarwal, Rajiv

“…Purpose of Review To explore the prevalence, treatment particularities, and research agenda in the management of resistant hypertension among patients with…”
Get full text

Unmasking hypertension in patients with chronic kidney disease: who to screen and how to confirm the diagnosis? by Georgianos, Panagiotis I, Vaios, Vasilios, Karligkiotis, Apostolos, Liakopoulos, Vassilios

Get full text

Slowing the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes Using Four Pillars of Therapy: The Time to Act is Now by Georgianos, Panagiotis I, Vaios, Vasilios, Koufakis, Theocharis, Liakopoulos, Vassilios

“…Chronic kidney disease (CKD) is the most common co-morbidity in patients with type 2 diabetes (T2D) and its presence substantially amplifies the risk for…”
Get full text

Opinion on exit-site care recommendations by Tsinari, Ariti, Roumeliotis, Stefanos, Varouktsi, Garyfallia, Georgianos, Panagiotis I, Vaios, Vasilios, Liakopoulos, Vassilios

Get full text

Albuminuria and cardiorenal risk by Georgianos, Panagiotis I., Dounousi, Evangelia, Liakopoulos, Vassilios

“…This article explores the prognostic association of albuminuria with the risk of adverse health outcomes and also provides an overview of novel…”
Get full text

Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis by Georgianos, Panagiotis I., Agarwal, Rajiv

“…Key Points Contrary to the reverse epidemiology of hypertension as assessed by peridialytic blood pressure (BP) recordings, interdialytic BP assessed either by…”
Get full text

Can We Study Hypertension in Patients on Dialysis? Yes We Can by Georgianos, Panagiotis I, Agarwal, Rajiv

Get full text